Search research articles
Contact Us
Filters
Showing results (1-10 of 104) with videos related to
Page
of 11
Sort By:
Clinical Rheumatology
|
March 21, 2021
B cells in systemic sclerosis: from pathophysiology to treatment
Konstantinos Melissaropoulos, Dimitrios Daoussis
Joint Bone Spine
|
November 20, 2021
Serotonin and systemic sclerosis. An emerging player in pathogenesis
Ioannis Sagonas, Dimitrios Daoussis
Clinical Rheumatology
|
February 27, 2023
Treatment of digital ulcers in systemic sclerosis: recent developments and future perspectives
Ioannis Sagonas, Dimitrios Daoussis
Rheumatology International
|
April 12, 2021
Renal dysfunction in systemic sclerosis beyond scleroderma renal crisis
George Iliopoulos, Dimitrios Daoussis
Rheumatology (Oxford, England)
|
September 13, 2016
Periaortitis, hairy kidneys and bone lesions
Pantelis Kraniotis, Dimitrios Daoussis
Mediterranean Journal of Rheumatology
|
March 19, 2020
ACTH vs betamethasone for the treatment of acute gout in hospitalized patients: A randomized, open label, comparative study
Dimitrios Daoussis, Panagiotis Kordas,
Rheumatology (Oxford, England)
|
December 1, 2010
Uric acid and cardiovascular risk in rheumatoid arthritis
Dimitrios Daoussis, George D Kitas
Mediterranean Journal of Rheumatology
|
March 19, 2020
Treatment of systemic sclerosis associated fibrotic manifestations: Current options and future directions
Dimitrios Daoussis, Stamatis-Nick Liossis
Seminars in Arthritis and Rheumatism
|
March 26, 2011
The emerging role of Dickkopf-1 in bone biology: is it the main switch controlling bone and joint remodeling?
Dimitrios Daoussis, Andrew P Andonopoulos
Rheumatology International
|
April 9, 2010
Rituximab in the treatment of systemic sclerosis-associated interstitial lung disease: comment on the article by Yoo
Dimitrios Daoussis, Andrew P Andonopoulos
Page
of 11
Search research articles
Search
Showing results (1-10 of 104) with videos related to
Sort By:
Page
of 11
Clinical Rheumatology
|
March 21, 2021
B cells in systemic sclerosis: from pathophysiology to treatment
Konstantinos Melissaropoulos, Dimitrios Daoussis
Joint Bone Spine
|
November 20, 2021
Serotonin and systemic sclerosis. An emerging player in pathogenesis
Ioannis Sagonas, Dimitrios Daoussis
Clinical Rheumatology
|
February 27, 2023
Treatment of digital ulcers in systemic sclerosis: recent developments and future perspectives
Ioannis Sagonas, Dimitrios Daoussis
Rheumatology International
|
April 12, 2021
Renal dysfunction in systemic sclerosis beyond scleroderma renal crisis
George Iliopoulos, Dimitrios Daoussis
Rheumatology (Oxford, England)
|
September 13, 2016
Periaortitis, hairy kidneys and bone lesions
Pantelis Kraniotis, Dimitrios Daoussis
Mediterranean Journal of Rheumatology
|
March 19, 2020
ACTH vs betamethasone for the treatment of acute gout in hospitalized patients: A randomized, open label, comparative study
Dimitrios Daoussis, Panagiotis Kordas,
Rheumatology (Oxford, England)
|
December 1, 2010
Uric acid and cardiovascular risk in rheumatoid arthritis
Dimitrios Daoussis, George D Kitas
Mediterranean Journal of Rheumatology
|
March 19, 2020
Treatment of systemic sclerosis associated fibrotic manifestations: Current options and future directions
Dimitrios Daoussis, Stamatis-Nick Liossis
Seminars in Arthritis and Rheumatism
|
March 26, 2011
The emerging role of Dickkopf-1 in bone biology: is it the main switch controlling bone and joint remodeling?
Dimitrios Daoussis, Andrew P Andonopoulos
Rheumatology International
|
April 9, 2010
Rituximab in the treatment of systemic sclerosis-associated interstitial lung disease: comment on the article by Yoo
Dimitrios Daoussis, Andrew P Andonopoulos
Page
of 11